‌

US Patent 8278093 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

Patent 8278093 was granted and assigned to Vical on October, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

‌

Vical

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

82780930

Patent Inventor Names

Gary G. Hermanson0

Mary Kopke Wloch0

Andrew J. Geall0

Date of Patent

October 2, 2012

Patent Application Number

130137520

Date Filed

January 25, 2011

Patent Citations Received

‌

US Patent 11951179 Lipid nanoparticle compositions and methods for MRNA delivery

‌

US Patent 12121592 Lipid nanoparticle compositions and methods for mRNA delivery

‌

US Patent 11951181 Lipid nanoparticle compositions and methods for mRNA delivery

‌

US Patent 11951180 Lipid nanoparticle compositions and methods for MRNA delivery

Patent Primary Examiner

‌

Bo Peng

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8278093 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API